FOLR2 and neoplasm: Table 3 provides a selection of approaches that have been reported for targeting FRβ-expressing macrophages in RA and RA-related diseases as well as for FRβ-expressing tumor-associated macrophages and FRβ-expressing acute myeloid leukemia cells.